Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Abbott’s Ross Division Shows Healthy Growth On Pediatric Nutritional Sales

This article was originally published in The Tan Sheet

Executive Summary

A double-digit sales increase for pediatric nutritional products leads Abbott Laboratories' Ross consumer healthcare division to its strongest quarter of the year
Advertisement

Related Content

Abbott Gains Sports, Weight-Loss Brands With EAS Acquisition
Abbott Gains Sports, Weight-Loss Brands With EAS Acquisition
Abbott Gains Sports, Weight-Loss Brands With EAS Acquisition
Abbott Taps Wrigley Exec To Lead Ross Unit
Abbott Taps Wrigley Exec To Lead Ross Unit
Hi-Tech Diabetic Products To Play Key Role In Firm’s Growth Strategy
Abbott To Spin Off Hospital Products Unit To Focus On High-Margin Products
Abbott’s Acquisition Of ZonePerfect Complements Medical Nutrition Business
California WIC “Listening Sessions” Will Address Lipid-Enhanced Formulas
California WIC “Listening Sessions” Will Address Lipid-Enhanced Formulas

Topics

Advertisement
UsernamePublicRestriction

Register

PS096025

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel